| 000 | 01235 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250517154124.0 | ||
| 264 | 0 | _c20180326 | |
| 008 | 201803s 0 0 eng d | ||
| 022 | _a1868-1891 | ||
| 024 | 7 |
_a10.1515/hmbci-2017-0002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSonoda, Junichiro | |
| 245 | 0 | 0 |
_aFGF21-receptor agonists: an emerging therapeutic class for obesity-related diseases. _h[electronic resource] |
| 260 |
_bHormone molecular biology and clinical investigation _cMay 2017 |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aEnergy Metabolism _xdrug effects |
| 650 | 0 | 4 |
_aFibroblast Growth Factors _xmetabolism |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aObesity _xdrug therapy |
| 650 | 0 | 4 | _aProtein Stability |
| 650 | 0 | 4 |
_aReceptor, Fibroblast Growth Factor, Type 1 _xagonists |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aTranscription, Genetic |
| 700 | 1 | _aChen, Mark Z | |
| 700 | 1 | _aBaruch, Amos | |
| 773 | 0 |
_tHormone molecular biology and clinical investigation _gvol. 30 _gno. 2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1515/hmbci-2017-0002 _zAvailable from publisher's website |
| 999 |
_c27191919 _d27191919 |
||